Egyszerű nézet

dc.contributor.author Ruppert, Mihály
dc.contributor.author Korkmaz-Icöz, Sevil
dc.contributor.author Li, Shiliang
dc.contributor.author Brlecic, Paige
dc.contributor.author Németh, Balázs Tamás
dc.contributor.author Oláh, Attila
dc.contributor.author Horváth, Eszter M
dc.contributor.author Veres, Gábor
dc.contributor.author Pleger, Sven
dc.contributor.author Grabe, Niels
dc.contributor.author Merkely, Béla
dc.contributor.author Karck, Matthias
dc.contributor.author Radovits, Tamás
dc.contributor.author Szabó, Gábor
dc.date.accessioned 2020-03-20T12:27:51Z
dc.date.available 2020-03-20T12:27:51Z
dc.date.issued 2019
dc.identifier 85065496758
dc.identifier.citation journalVolume=9;pagination=1869, pages: 16;journalTitle=FRONTIERS IN PHYSIOLOGY;journalAbbreviatedTitle=FRONT PHYSIOL;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/8182
dc.identifier.uri doi:10.3389/fphys.2018.01869
dc.description.abstract Background: Pressure unloading induces the regression of left ventricular myocardial hypertrophy (LVH). Recent findings indicate that pharmacological activation of the soluble guanylate cyclase (sGC) - cyclic guanosine monophosphate (cGMP) pathway may also exert reverse-remodeling properties in the myocardium. Therefore, we aimed to investigate the effects of the sGC activator cinaciguat in a rat model of LVH and compare it to the "gold standard" pressure unloading therapy. Methods: Abdominal aortic banding was performed for 6 or 12 weeks. Sham operated animals served as controls. Pressure unloading was induced by removing the aortic constriction after week 6. The animals were treated from week 7 to 12, with 10 mg/kg/day cinaciguat or with placebo p.o., respectively. Cardiac function and morphology were assessed by left ventricular pressure-volume analysis and echocardiography. Additionally, key markers of myocardial hypertrophy, fibrosis, nitro-oxidative stress, apoptosis and cGMP signaling were analyzed. Results: Pressure unloading effectively reversed LVH, decreased collagen accumulation and provided protection against oxidative stress and apoptosis. Regression of LVH was also associated with a full recovery of cardiac function. In contrast, chronic activation of the sGC enzyme by cinaciguat at sustained pressure overload only slightly influenced pre-established hypertrophy. However, it led to increased PKG activity and had a significant impact on interstitial fibrosis, nitro-oxidative stress and apoptosis. Amelioration of the pathological structural alterations prevented the deterioration of LV systolic function (contractility and ejection fraction) and improved myocardial stiffness. Conclusion: Our results indicate that both cinaciguat treatment and pressure unloading evoked anti-remodeling effects and improved LV function, however in a differing manners.
dc.relation.ispartof urn:issn:1664-042X
dc.title Comparison of the Reverse-Remodeling Effect of Pharmacological Soluble Guanylate Cyclase Activation With Pressure Unloading in Pathological Myocardial Left Ventricular Hypertrophy
dc.type Journal Article
dc.date.updated 2020-02-05T10:01:18Z
dc.language.rfc3066 en
dc.rights.holder NULL
dc.identifier.mtmt 30408874
dc.identifier.wos 000455140800001
dc.identifier.pubmed 30670980
dc.contributor.department SE/AOK/K/VAROSMAJOR_SZÍVÉRGYÓGY/Kardiológia Központ - Kardiológiai Tanszék
dc.contributor.department SE/AOK/I/Élettani Intézet
dc.contributor.institution Semmelweis Egyetem
dc.mtmt.swordnote Radovits T és Szabó G megosztott utolsó szerzők.


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet